FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105605 [Registered on: 09/03/2026] Trial Registered Prospectively
Last Modified On: 06/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Detecting Stomach Infection (H. pylori) Using a Smart Breath Test. 
Scientific Title of Study   A Smart Breath Analysis System for Non-Invasive Detection of Urease Activity in Helicobacter pylori Patients 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  GUNDETI THARUN REDDY 
Designation  Post graduate, General medicine 
Affiliation  Saveetha medical college and hospital 
Address  Department of general medicine, Saveetha medical college and hospital, saveetha nagar, Thandalam, Chennai Chennai TAMIL NADU 602105 India

Kancheepuram
TAMIL NADU
602105
India 
Phone  9890901617  
Fax    
Email  Tarunreddy3635@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MARIRAJ I 
Designation  Professor 
Affiliation  Saveetha medical college and hospital 
Address  Department of general medicine, Saveetha medical college and hospital, saveetha nagar, Thandalam, Chennai Chennai TAMIL NADU 602105 India

Kancheepuram
TAMIL NADU
602105
India 
Phone  7299376822  
Fax    
Email  justmariraj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  GUNDETI THARUN REDDY 
Designation  Post graduate general medicine  
Affiliation  Saveetha medical college and hospital 
Address  Department of general medicine, Saveetha medical college and hospital, saveetha nagar, Thandalam, Chennai Chennai TAMIL NADU 602105 India

Kancheepuram
TAMIL NADU
602105
India 
Phone  9890901617  
Fax    
Email  Tarunreddy3635@gmail.com  
 
Source of Monetary or Material Support  
Saveetha medical college and hospital, Saveetha Nagar, Thandalam, Chennai- 602105, Chennai, Tamil Nadu  
 
Primary Sponsor  
Name  Saveetha medical college and hospital  
Address  Saveetha nagar, Thandalam, Chennai- 602105, Chennai, Tamil Nadu  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Gundeti Tharun Reddy  Saveetha medical college and hospital   Department of general medicine, Saveetha nagar, Thandalam, Chennai- 602105, TAMIL NADU Chennai TAMIL NADU
Kancheepuram
TAMIL NADU 
9890901617

Tarunreddy3635@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Saveetha medical college and hospital institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B968||Other specified bacterial agents as the cause of diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Individuals aged 18 years and above.

2)Patients presenting with gastrointestinal symptoms suggestive of Helicobacter pylori infection (e.g., upper abdominal pain, bloating, nausea).

3)Patients who are willing and able to provide informed consent.

4)Participants willing to undergo both the smart breath analyzer test and standard diagnostic procedures for H. pylori.
 
 
ExclusionCriteria 
Details  1)Patients who have taken antibiotics, proton pump inhibitors (PPIs), or bismuth compounds within the last 4 weeks.

2)History of gastrectomy or major gastrointestinal surgery.

3)Pregnant or breastfeeding women.

4)Patients with severe respiratory conditions (e.g., COPD) that may interfere with breath sampling.

5)Individuals with known allergies to the urea test substrate.

6)Patients unable to comply with study procedures or follow-up.

7)Cognitively impaired individuals unable to give informed consent.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To develop and evaluate a novel smart breath analyzer capable of accurately detecting Helicobacter pylori infection by measuring urease activity in exhaled breath, offering a non-invasive, rapid, and user-friendly diagnostic alternative to conventional methods.
 

Day 0 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the diagnostic accuracy (sensitivity, specificity, PPV, NPV) of the smart breath analyzer with the standard urea breath test and/or endoscopic biopsy-based methods.


To assess the usability and patient compliance associated with the smart breath analyzer in clinical and outpatient settings.


To evaluate the real-time data processing and interpretation capabilities of the device’s integrated smart interface.
 
Day 0, day 2 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This research evaluates a novel smart breath analyzer designed to detect Helicobacter pylori infection by measuring urease activity in exhaled breath. The study will be conducted at Saveetha Medical College on 30 adults with gastrointestinal symptoms suggestive of H. pylori. Participants will perform the breath test after ingesting a urea solution, and results will be compared with standard diagnostic methods. The main objective is to determine the diagnostic accuracy (sensitivity and specificity) of the device. The study also assesses patient comfort, usability, and time to obtain results. If successful, the device could provide a rapid, non-invasive, and cost-effective alternative for diagnosing H. pylori.  


 
Close